Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Selective serotonin reuptake inhibitor poisoning

INTRODUCTION

The selective serotonin reuptake inhibitors (SSRIs) were introduced in the late 1980s for the treatment of depression. They are generally much safer in overdose than tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). Commonly used SSRIs include fluoxetine, sertraline, paroxetine, and citalopram.

In 2004, SSRIs accounted for 48,204 reported exposures to US poison centers with 103 fatalities; the vast majority of these fatalities were associated with coingestants [1]. The incidence of SSRI ingestions has steadily increased and mirrors the increase in SSRI prescriptions [2]. Isolated SSRI ingestions generally produce mild symptoms, although SSRI intoxication can infrequently produce serotonin syndrome, seizures, CNS depression, or various cardiac abnormalities.

The toxicity and management of acute SSRI overdose will be discussed here. A summary table to facilitate emergent management of SSRI poisoning is provided (table 1). Discussions of the therapeutic use of these medications, and of serotonin syndrome, are found elsewhere. (See "Antidepressant medication in adults: SSRIs and SNRIs" and "Serotonin syndrome".)

PHARMACOLOGY AND CELLULAR TOXICOLOGY

Serotonin is produced from tryptophan, while norepinephrine and dopamine are produced from tyrosine, through similar chemical pathways in nerve terminals. These neurotransmitters are stored in cytoplasmic vesicles of presynaptic neurons and released into the synapse with nerve depolarization. Transport proteins specific for serotonin, norepinephrine, or dopamine are embedded in the presynaptic terminal cell membrane and are responsible for pumping these neurotransmitters out of the synapse and back into the cytoplasm. Once in the cytoplasm, the neurotransmitters are either repackaged into vesicles for reuse or degraded by monoamine oxidase.

Approximately 98 percent of the body's serotonin is found outside the central nervous system (CNS). Several families of serotonin receptors, with multiple subtypes, have been discovered. In the CNS, serotonergic neurons are found in the brainstem, mostly in the raphe nucleus. They have a role in regulating mood, personality, appetite, wakefulness, emesis, temperature regulation, and sexual behavior [3]. Peripherally, serotonin aids in regulating vascular tone, peristalsis, and platelet activation.

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Watson, WA, Litovitz, TL, Rodgers, GC Jr, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589.
  2. Townsend, E, Hawton, K, Harriss, L, et al. Substances used in deliberate self-poisoning 1985-1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36:228.
  3. Boyer, EW, Shannon, M. The serotonin syndrome. N Engl J Med 2005; 352:1112.
  4. Prozac Package Insert 2005. Eli Lilly and Company (www.lilly.com).
  5. Graudins, A, Dowsett, RP, Liddle, C. The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin-specific antidepressants. Emerg Med (Fremantle) 2002; 14:440.
  6. Mason, J, Freemantle, N, Eccles, M. Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract 2000; 50:366.
  7. Stoner, SC, Marken, PA, Watson, WA, et al. Antidepressant overdoses and resultant emergency department services: the impact of SSRIs. Psychopharmacol Bull 1997; 33:667.
  8. Henry, JA, Alexander, CA, Sener, EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310:221.
  9. Buckley, NA, McManus, PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325:1332.
  10. Isbister, GK, Bowe, SJ, Dawson, A, Whyte, IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277.
  11. Barbey, JT, Roose, SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59 Suppl 15:42.
  12. Fabian, TJ, Amico, JA, Kroboth, PD, et al. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Geriatr Psychiatry Neurol 2003; 16:160.
  13. Movig, KL, Leufkens, HG, Lenderink, AW, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 2002; 53:363.
  14. Nahshoni, E, Weizman, A, Shefet, D, Pik, N. A case of hyponatremia associated with escitalopram. J Clin Psychiatry 2004; 65:1722.
  15. Ganetsky, M, Brush, E. Serotonin syndrome - what have we learned? Clin Ped Emerg Med 2005; 6:103.
  16. Spiller, HA, Morse, S, Muir, C. Fluoxetine ingestion: a one year retrospective study. Vet Hum Toxicol 1990; 32:153.
  17. Wernicke, JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985; 46:59.
  18. Borys, DJ, Setzer, SC, Ling, LJ, et al. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992; 10:115.
  19. Chiang, WK, Ford, MK, Wax, PM, et al. Prospective evaluation of fluoxetine ingestions (abstract). Vet Hum Toxicol 1990; 32:348.
  20. Phillips, S, Brent, J, Kulig, K, et al. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group. J Emerg Med 1997; 15:439.
  21. Moore, JL, Rodriguez, R. Toxicity of fluoxetine in overdose. Am J Psychiatry 1990; 147:1089.
  22. Compton, R, Spiller, HA, Bosse, GM. Fatal fluoxetine ingestion with postmortem blood concentrations. Clin Toxicol (Phila) 2005; 43:277.
  23. Kincaid, RL, McMullin, MM, Crookham, SB, Rieders, F. Report of a fluoxetine fatality. J Anal Toxicol 1990; 14:327.
  24. Rohrig, TP, Prouty, RW. Fluoxetine overdose: a case report. J Anal Toxicol 1989; 13:305.
  25. Gross, R, Dannon, PN, Lepkifker, E, et al. Generalized seizures caused by fluoxetine overdose. Am J Emerg Med 1998; 16:328.
  26. Braitberg, G, Curry, SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med 1995; 26:234.
  27. Riddle, MA, Brown, N, Dzubinski, D, et al. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989; 28:587.
  28. Graudins, A, Vossler, C, Wang, R. Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy. Am J Emerg Med 1997; 15:501.
  29. Cooper, GL. The safety of fluoxetine--an update. Br J Psychiatry Suppl 1988; :77.
  30. Gardner, SF, Rutherford, WF, Munger, MA, Panacek, EA. Drug-induced supraventricular tachycardia: a case report of fluoxetine. Ann Emerg Med 1991; 20:194.
  31. Roberge, RJ, Martin, TG. Mixed fluoxetine/loxapine overdose and atrial flutter. Ann Emerg Med 1994; 23:586.
  32. McAnally, LE, Threlkeld, KR, Dreyling, CA. Case report of a syncopal episode associated with fluoxetine. Ann Pharmacother 1992; 26:1090.
  33. Ahmed, I, Dagincourt, PG, Miller, LG, Shader, RI. Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry 1993; 38:62.
  34. Hofman, M, Liu, JK. Conduction abnormality and ventricular tachyarrhythmia associated with fluoxetine overdose (abstract). Vet Hum Toxicol 1994; 36:371.
  35. Appleby, M, Mbewu, A, Clarke, B. Fluoxetine and ventricular torsade--is there a link?. Int J Cardiol 1995; 49:178.
  36. Doogan, DP. Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol 1991; 6 Suppl 2:47.
  37. Caracci, G. Unsuccessful suicide attempt by sertraline overdose. Am J Psychiatry 1994; 151:147.
  38. Klein-Schwartz, W, Anderson, B. Analysis of sertraline-only overdoses. Am J Emerg Med 1996; 14:456.
  39. Lau, GT, Horowitz, BZ. Sertraline overdose. Acad Emerg Med 1996; 3:132.
  40. Boyer, WF, Blumhardt, CL. The safety profile of paroxetine. J Clin Psychiatry 1992; 53 Suppl:61.
  41. Myers, LB, Dean, BS, Krenelok, EP. Paroxetine (Paxil): overdose assessment of a new selective serotonin reuptake inhibitor (abstract). Vet Hum Toxicol 1994; 36:370.
  42. Tonks, A. Withdrawal from paroxetine can be severe, warns FDA. BMJ 2002; 324:260.
  43. Garnier, R, Azoyan, P, Chataigner, D, et al. Acute fluvoxamine poisoning. J Int Med Res 1993; 21:197.
  44. Black, DW, Wesner, R, Gabel, J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993; 54:146.
  45. Tan, JY, Levin, GM. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy 1999; 19:675.
  46. Personne, M, Sjoberg, G, Persson, H. Citalopram overdose--review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997; 35:237.
  47. Personne, M, Persson, H, Sjoberg, E. Citalopram toxicity. Lancet 1997; 350:518.
  48. Celexa Package Insert (2005). Forest Pharmaceuticals, http://www.frx.com/pi/celexa_pi.pdf (Accessed March 23, 2006).
  49. Rasmussen, SL, Overo, KF, Tanghoj, P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol 1999; 19:407.
  50. Grundemar, L, Wohlfart, B, Lagerstedt, C, et al. Symptoms and signs of severe citalopram overdose. Lancet 1997; 349:1602.
  51. Kelly, CA, Dhaun, N, Laing, WJ, et al. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42:67.
  52. Catalano, G, Catalano, MC, Epstein, MA, Tsambiras, PE. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24:158.
  53. Engebretsen, KM, Harris, CR, Wood, JE. Cardiotoxicity and late onset seizures with citalopram overdose. J Emerg Med 2003; 25:163.
  54. Meuleman, C, Jourdain, P, Bellorini, M, et al. [Citalopram and Torsades de Pointes. A case report]. Arch Mal Coeur Vaiss 2001; 94:1021.
  55. Tarabar, AF, Hoffman, RS, Nelson, LS. Citalopram overdose: late presentation of Torsades de Pointes (TdP) with cardiac arrest (abstract #86). J Toxicol Clin Toxicol 2003; 41:676.
  56. Snider, RD. Case report: left bundle branch block--a rare complication of citalopram overdose. J S C Med Assoc 2001; 97:380.
  57. Rothenhausler, HB, et al. Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker. Pharmacopsychiatry 2000; 33:150.
  58. Cuenca, PJ, Holt, KR, Hoefle, JD. Seizure secondary to citalopram overdose. J Emerg Med 2004; 26:177.
  59. Ostrom, M, Eriksson, A, Thorson, J, Spigset, O. Fatal overdose with citalopram. Lancet 1996; 348:339.
  60. Escitalopram (lexapro) for depression. Med Lett Drugs Ther 2002; 44:83.
  61. van Gorp, F, Whyte, IM, Isbister, GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med 2009; 54:404.
  62. Barnett, AK, Brush, DE, Schroeder, W. The pharmacology and toxicology of escitalopram. Int J Med Toxicol 2003; 6:14.
  63. Lexapro Package Insert (2005), Forest Pharmaceuticals, http://www.frx.com/pi/lexapro_pi.pdf (Accessed March 23, 2006).
  64. Abstracts of the North American Congress of Clinical Toxicology Annual Meeting. September 4-9, 2003. Chicago, Illinois, USA. J Toxicol Clin Toxicol 2003; 41:641.
  65. Ginsburg, BY, Wiener, SW, Henderson, KJ, et al. QTc interval prolongation associated with escitalopram overdose (abstract #174). J Toxicol Clin Toxicol 2005; 43:502.
  66. Scharko, AM, Schumacher, J. Prolonged QTc interval in a 14-year-old girl with escitalopram overdose. J Child Adolesc Psychopharmacol 2008; 18:297.
  67. Yuksel, FV, Tuzer, V, Goka, E. Escitalopram intoxication. Eur Psychiatry 2005; 20:82.
  68. Olsen, DG, Dart, RC, Robinett, M. Severe serotonin syndrome from escitalopram overdose. J Toxicol Clin Toxicol 2004; 42:744.
  69. Huska, MT, Catalano, G, Catalano, MC. Serotonin syndrome associated with the use of escitalopram. CNS Spectr 2007; 12:270.
  70. Lindgren, KN, et al. Escitalopram, a review of adverse effects in overdose reported to select regional poison centers (abstract #41). J Toxicol Clin Toxicol 2003; 41:658.
  71. Chyka PA, Seger D, Krenzelok EP, et al. Position paper: Single-dose activated charcoal. Clin Toxicol 2005; 43:61.
  72. Isbister, GK, Friberg, LE, Stokes, B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007; 50:593.
  73. Keren, A, Tzivoni, D. Torsades de pointes: prevention and therapy. Cardiovasc Drugs Ther 1991; 5:509.
  74. Baker, SD, Morgan, DL. Fluoxetine exposures: are they safe for children?. Am J Emerg Med 2004; 22:211.
  75. Myers, LB, Dean, BS, Krenzelok, EP. Sertraline (Zoloft): a pediatric overdose approach (abstract). Vet Human Toxicol 1994; 36:361.
  76. Myers, LB, Krenzelok, EP. Paroxetine (Paxil) overdose: a pediatric focus. Vet Hum Toxicol 1997; 39:86.
  77. Fraser, J, South, M. Life-threatening fluvoxamine overdose in a 4-year-old child. Intensive Care Med 1999; 25:548.
  78. Horowitz, BZ, Mullins, ME. Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion. Pediatr Emerg Care 1999; 15:325.
  79. Kaminski, CA, Robbins, MS, Weibley, RE. Sertraline intoxication in a child. Ann Emerg Med 1994; 23:1371.
  80. Gill, M, LoVecchio, F, Selden, B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999; 33:457.
  81. Mosby's drugconsult. Mosby, St. Louis 2002. p.v.
  82. Hale, TW, Shum, S, Grossberg, M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr (Phila) 2001; 40:681.
  83. Isbister, GK, Dawson, A, Whyte, IM, et al. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?. Arch Dis Child Fetal Neonatal Ed 2001; 85:F147.
white circle LOG IN
white circle DEMO